Efficacy and Safety of Once-weekly Dulaglutide Versus Insulin Glargine in Mainly Asian Patients with Type 2 Diabetes Mellitus on Metformin and/or a Sulfonylurea: a 52-week Open-label, Randomized Phase 3 Trial

Published 2018 View Full Article

Authors

Keywords

Journal

DIABETES OBESITY & METABOLISM

Volume -, Issue -, Pages -

Publisher

Wiley

Online

2018-08-22

DOI

10.1111/dom.13506

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

DIABETES OBESITY & METABOLISM

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Become a Peeref-certified reviewer